from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0724/sppA

LFCtreatmentdescriptionclass of inhibitor

-2.247

Amikacinug/mL Amikacintranslation

-0.745

Cap5-10ug/mL Capreomycintranslation

-0.903

Rox10-50 ug/mL Roxithromycintranslation

-0.109

SM2-5 ug/mL Streptomycintranslation

-2.205

Tet5-10 ug/mL Tetracyclinetranslation

-1.372

Rif0.2-5ug/mL Rifampicintranscription

-1.351

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.822

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.956

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.371

CPZ10-50 ug/mL Chlorpromazinerespiration

1.480

Clofazimine10-13 ug/mL Clofaziminerespiration

0.357

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.237

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.103

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.073

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.476

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.926

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.128

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.509

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.249

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.969

KCN5-20 ug/mL Potassium cyaniderespiration

1.023

NaN30.2-2 mM Sodium aziderespiration

-0.152

Nigericin50 uM Nigericinrespiration

0.703

TRC10-150 ug/mL Triclosanrespiration

1.487

TRZ10-25 ug/mL Thioridazinerespiration

-0.617

Valinomycin0.5-10 uM Valinomycinrespiration

0.036

ZnSO42 mM ZnSO4respiration

0.929

menadione6-10 ug/mL Menadionerespiration

0.120

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.473

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.717

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.442

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.141

NRP_1Non-replicating persistence stage 1dosRassociated

-0.091

Amp0.2mg/mL AmpicillincellWall

-0.438

Cephalexin20-100 ug/mL CephalexincellWall

-0.299

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.396

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.194

EMB10-20 ug/mL EthambutolcellWall

0.125

Eta12-40 ug/mL EthionamidecellWall

-0.203

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.081

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.739

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.617

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.098

BZA0.12 mg/mL BenzamidearomaticAmides

-0.185

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.664

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.014

H2O24 mM hydrogen peroxideDNAdamaging

-0.793

Levo10 ug/mL LevofloxacinDNAdamaging

-0.266

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.300

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.955

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.063

UVUV-irradiationDNAdamaging

0.531

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.549

Antimycin12.5-50 ug/mL Antimycin A?

-0.330

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.147

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.208

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.375

PA8240.2-2 ug/mL PA-824?

1.439

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.071

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.140

Verapamil50 uM Verapamil?

-0.196

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.230

methoxatin10-20 ug/mL Methoxatin?